IP Verse

Variants Of C-Type Natriuretic Peptide

Patent No. EP3175863 (titled "Variants Of C-Type Natriuretic Peptide") was filed by Biomarin Pharmaceutical on May 20, 2010. The application was issued on Dec 1, 2021.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_439/2025May 19, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersCounter Claim For Revocation
UPC_CFI_18/2025Jan 13, 2025Biomarin PharmaceuticalInfringement

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ASCENDIS PHARMAApr 10, 2025CARPMAELS & RANSFORD
ASCENDIS PHARMA GROWTH DISORDERSSep 1, 2022CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3175863

BIOMARIN PHARMACEUTICAL
Application Number
EP16192229A
Filing Date
May 20, 2010
Status
Granted And Under Opposition
Oct 29, 2021
Publication Date
Dec 1, 2021
External Links
Slate, EP3175863B1, Google Patents